A study conducted by the Duke University showed that Chiranjeevi Yojana of Gujarat failed to reduce the maternal mortality rate (MMR) and infant mortality rate (IMR) significantly.
The study was published by the international public health, Bulletin of the World Health Organisation (WHO) in the last week of December 2013.
The Cheeranjavi Yojana launched in 2006 to reduce the MMR and IMR, according to the study, did not lead to increased probability of institutional child-delivery or maternal health outcomes. Also, the Yojana did not led to any fall in the household expenditure on private-sector deliveries.
The reasons for the failure cited by the study are as follows:
• The inaccurate BPL classification of the population is a contributing factor. That is, 40 percent of above BPL have BPL cards and 45 percent BPL do not have BPL cards. This shows a clear case of leakage and benefits not reaching the targeted population.
• The providers were charging extra for other services and also lot of empanelled hospitals were in the urban areas that led to huge cost of access to these services.
• It also did not address self-selection of women into institutional delivery or reported inaccuracies by hospitals
About Chiranjeevi Yojana
Gujarat government launched Chiranjeevi Yojana in 2005-06 to reduce maternal and infant mortality rate in the state and increase the institutional delivery rates.
It covers the cost of deliveries at designated private sector hospitals for women from Below poverty Line households.
It pays 1600 rupees per delivery to the hospitals to provide free deliveries and reimburses at least some of the women’s travel costs.
In 2006, the programme received the Asian Innovations Award and considered this scheme should be replicated in other states.
If you have any Question/Point on the above information, please ask/discuss it in the Current Affairs Group
Who: Duke University
When: December 2013
DISCLAIMER: JPL and its affiliates shall have no liability for any views, thoughts and comments expressed on this article.